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During the purification process, monoclonal antibodies may be exposed to parts of UV-C 
(200 to 290 nm), UV-B (290 to 320 nm) and visible light (400 to 760 nm) under a variety of 
buffer and pH conditions.  Together, these conditions can promote both chemical and physical 
degradation which may result in conformational changes.  To examine this possibility, the 
impact of UV light on an IgG1 mAb at pH 3.5, 5 and 8 was studied at multiple protein 
concentrations.  Exposure to 302 nm light resulted in a pH-dependent formation of high 
molecular weight species where the degree of oligomerization increased with increasing pH.  
Characterization by SDS-PAGE under reducing and non-reducing conditions, and SEC-MALS, 
revealed that the predominant species were non-reducible dimeric, trimeric and higher order 
oligomeric species which occurred through processes other than intermolecular disulfide bond 
formation.  Biophysical characterization by differential scanning calorimetry demonstrated an 
overall loss of heat capacity suggesting a loss of conformational integrity with light exposure.  A 
decrease in tryptophan fluorescence was paralleled by a significant decrease in the transition 
temperature measured during heat-induced unfolding following light exposure also suggesting a 
significant change in conformational integrity.  The observations by fluorescence spectroscopy 
coincided with pH dependent changes in the alterations of secondary structure characterized by 
Fourier transform infrared spectroscopy and far UV circular dichroism with the most acidic pH 
showing the greatest degree of change in the β-sheet structure.  Exposure to UV light resulted in 
aggregation with pH-dependent yields decreasing in the following order, 8.0>5.0>3.5, while the 
opposite trend was observed for conformational changes, with pH-dependent extents decreasing 
in the following order:3.5>5.0>8.0.  These pH-dependent trends suggest that different strategies 
will be required to stabilize the protein against these modifications during processing. 
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Introduction: 
During the protein purification process, antibody products may be exposed to various 
types of light which are known to degrade proteins.1  Chromatographic purification steps 
typically use detectors that monitor elution of the antibody at both 280nm and 300nm.2,3  In 
between purification steps, the antibody may be held in large stainless steel or plastic containers 
that may not be protected from light and, therefore, exposed to ambient fluorescent lighting for 
up to one day.1  In fact, it has been shown that typical commercially available fluorescent tube 
lights emit UV light of wavelengths as short as 254 nm in appreciable amounts ranging 
approximately from 10-10 to 10-5 W/cm2/nm.4,5  While this amount of exposure is low, on the 
order of 8.7x10-4 to 87 J/cm2 at 302nm for an 8 hour day, it still means that antibodies are 
generally exposed to parts of UV-C (200 to 290nm), UV-B (290 to 320nm) and visible light (400 
to 760 nm) during the purification process.  Additionally, at various stages of purification, the 
antibody experiences a variety of buffers and buffer conditions ranging from pH 3-8.6-8 
Protein degradation pathways 
The characteristics of the native protein’s primary, secondary, tertiary, and quaternary 
structure help determine a protein’s ability to degrade.9  Protein degradation can result from a 
large number of environmental factors such as temperature, light, the presence of oxidizing 
agents, and pH.10  A number of additional stresses can also result in protein degradation.  These 
stresses include freeze-thaw, shaking, shear stress, as well as liquid-surface and liquid-air 
interfaces.9,11 
There are two pathways that proteins can degrade; chemical and physical.11-14  Chemical 
degradation of proteins can proceed via a number of reactions.  Hydrolysis involves either the 
cleavage of peptide bonds or deamidation of asparagines and glutamine residues.15,16  Oxidation 
of the side chains of histidine, methionine12, cysteine, tryptophan and tyrosine residues may 
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occur.15  These residues, as well as the peptide backbone,11 may also be susceptible to 
photooxidation.11,15  Additional chemical degradation may take the form of incorrect disulfide 
formation/shuffling, racemization, and pyroglutamic acid formation.11,15-17  Cysteine, serines, 
threonine, phenylalanine and lysine residues can also undergo β-elimination under alkaline 
conditions.15,16 
Physical instability of proteins can be caused by a change in the protein’s conformation 
which plays an important role in the therapeutic action of the protein.10,14  Denaturation or the 
unfolding of a protein, resulting in changes in the protein’s tertiary or secondary structure have 
been observed under a variety of conditions ranging from changes in temperature, pH, buffer, 
physical agitation, or the addition of organic solvents or other denaturants.17  Denaturation may 
be either reversible or irreversible.15  Aggregation is still another major source of protein 
physical degradation and involves the assembly of either covalently or non-covalently linked 
protein molecules.11  Aggregation may proceed via a number of mechanisms.18  Reversible self 
association of monomers in native conformation is one such mechanism.18  Aggregation may 
also occur when there is a change in conformation or unfolding of the native protein which 
allows for two or more protein molecules to associate.14  Taking this mechanism one step further, 
the change in conformation may be the result of chemical modifications of the protein.  Once an 
aggregate is formed, it can form the nucleus for further aggregation.18  As mentioned above, the 
disulfide structure may be altered forming intermolecular disulfide bonds.14  Surface adsorption 
of therapeutic proteins resulting in loss of protein is classified as a physical instability and may 
also lead to aggregation.14-16,18,19  Complicating matters is that often chemical degradation goes 
hand in hand with physical degradation.  Physical degradation in the form of denaturation may 
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lead to chemical degradation, or chemical degradation may result in conformational changes and 
or aggregation.17 
Immunogenicity of proteins 
The topic of protein degradation takes on added importance because of the increased 
potential for an immunogenic response in patients upon administration of protein therapeutics, 
even for self proteins (autologous proteins).  Immunogenicity occurs when a substance is able to 
stimulate or induce a noticeable immune response in a given subject.20  Immune responses can 
range from simply neutralizing the desired therapeutic action for the protein to anaphylactic 
shock and patient fatality.21  More specifically, immune responses to protein therapeutics can 
take several different forms ranging from acute infusion or injection site reactions that are 
anaphylactic or pseudo-allergic/analphylactoid, serum sickness, and effects corresponding to the 
formation of antibodies against the protein therapeutic that in turn attack endogenous proteins.9 
Immune responses to foreign proteins (exogenous proteins), commonly referred to as “the 
classical immune response” occurs through a T-cell dependent pathway.9  Here, the targeted 
protein is captured by antigen-presenting cells (APCs) and digested producing peptides referred 
to as T-cell epitopes which are then presented as major histocompatibility complex (MHC) Class 
II molecules on the cell’s surface.9  These peptides are then recognized by T cells and 
subsequently activate B cells which generate antibody secreting plasma B cells, both long and 
short lived.  In the process, some of the B cells become memory cells, which maintain a number 
of long term plasma cells and allow for a rapid immune response should the host be rechallenged 
with the foreign protein.9  The other process by which an immune response may be triggered is 
the T cell independent pathway.  In this case the targeted protein or antigen is encased by 
specialized bloodbourne peripheral dendritic cells, which then make their way to the host’s 
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spleen.  At the spleen, the antigen is presented to B cells.  This pathway has been used to 
describe the immune response for particulate antigens typically bacterial or viral in origin and for 
aggregates in biotherapeutics.9  
Unfortunately, no specific property of proteins can be used to predict whether a particular 
protein will trigger an immune response or not.9  The complexity of immunogenicity arises from 
the large number of factors that can play a role in triggering an immune response.  These factors 
can be separated into two categories.  The first being related to the patient and include:  genetics, 
any disease state(s), medications and treatment regimen.  The second being associated with 
product related factors classified as CMC-related factors such as the primary sequence and 
design of the protein, manufacturing process, formulation, container, and stability.9  Among the 
CMC-related factors is the exposure to light during manufacturing.9 
Protein chemical degradation pathways that can produce an immune response in patients, 
include:  deamidation, deimination, glycosylation, hydroxylation, isomerization, methylation, 
and phosphorylation.9  Of these, only deamidation and oxidation are typically seen in vitro and 
neither have been documented in the clinic as the direct cause of an immune response.9  Despite 
this, protein oxidation remains a primary concern9 with the  immunogenicity of the protein in 
question being highly dependent upon the nature of that protein and the particular residues that 
have become oxidized.20  Protein conformation10 and aggregation have both been cited as leading 
causes for protein therapeutics to be immunogenic.9,20-22  Aggregation of proteins, either native, 
partially, or completely unfolded can potentially lead to an immune response.9  Therefore, 
changes in protein conformation such as those caused by chemical modifications can still play a 
significant role in eliciting an immune response.21  Additionally, proteins experience a great 
number of stresses that can lead to aggregation during the manufacturing, purification, 
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formulation, and packaging steps.  A brief list of these factors include:  pH, temperature, 
concentration, ionic strength, freeze-thaw stress, shear stress, interfacial stresses at the liquid 
surfaces, and mechanical stresses.9,21  Different stresses may produce different size distributions 
and types of aggregates and may even contain different secondary and tertiary structures 
potentially causing different immune responses in patients.21 
Chemistry of photooxidation 
The photo-oxidation of proteins proceeds via type I or type II photoprocesses.23,24  Type I 
photooxidation proceeds via singlet or triplet excited states of amino acids, or via photo-
ionization.25  Type II photooxidation involves intermediary singlet oxygen (1O2)23,24 but is 
generally considered less efficient for protein amino acid residues.23  Direct photo-oxidation of 
proteins by a Type I process typically occurs at λ ≤  320 nm and is only significant at λ > 320 nm 
if the protein contains a bound  co-factor or functional group that is able to absorb light at higher 
wavelengths.24  The amino acid residues of tryptophan, tyrosine, phenylalanine and cystine 
absorb near UV light while all of the remaining amino acids do not absorb significantly at λ 
>230 nm.  Specifically, tryptophan absorbs between 280-305 nm, tyrosine between 260-290 nm, 
phenylalanine between 240-270 nm, and finally cystine between 250-300 nm.1  The n to π* 
transition associated with the peptide bond is observed at 180-220nm.26  Of primary interest to 
the current paper is the photodegradation of tryptophan and cystine residues.  The 
photodegradation of tryptophan residues has been studied extensively27,28 and a number of 
photoproducts have been characterized, including the fluorescent products N-formylkynurenine 
and kynurenine.1  An important feature of tryptophan photolysis is the potential for photoinduced 
electron transfer to nearby disulfide bridges1 where disulfide reduction leads to a thiolate and a 
thiyl radical.1  Thiyl radicals can form also via direct light-induced homolysis of cystine disulfide 
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bonds29-32 and a number of reaction products have been characterized for thiyl radical pairs 
generated in such way1,33-37 For completeness, we note that disulfide bonds can also cleave via 
C-S bond breakage into carbon-centered radicals and perthiyl radicals, but this process appears to 
prevail for β-alkyl substituted disulfides such as, for example, penicillamine.30  For comparison, 
the light-induced cleavage of glutathione disulfide led predominantly to thiyl radicals.30 
It is well documented that radical mediated damage to proteins may lead to a variety of 
potentially negative consequences such as fragmentation23,38, aggregation25,38,39, oxidation40-43, 
changes to surface hydrophobicity, conformational changes39 and even denaturation.38,39  It may 
also ultimately result in the loss of activity or simply generate new reactive species propagating 
the radical reactions.44  An examination of the photo-stability of monoclonal antibodies (mAbs) 
under conditions similar to those observed during purification may provide insights as to how 
best to avoid these negative consequences. 
Prior work on protein photodegradation 
A number of studies have examined the photodegradation of monoclonal antibodies 
under a variety of conditions using broad spectrum light between 300-800 nm.25,38,41-43  Common 
to all of these studies was photodegradation resulting in the oxidation of tryptophan38,43 and 
methionine38,41,42 with differences noted in specific regions of each antibody.  Qi et al. observed 
substantial oxidation of light chain Trp94 in the CDR resulting in multiple oxidation products 
along with secondary oxidation of Met261, Met437 and His294 of the heavy chain.  
Interestingly, oxidation of Trp94 was accompanied by cyclization and deamidation of Asn93 
along with a concurrent loss of bioactivity.38  A similar loss of bioactivity with the loss of Trp in 
the CDR was also observed for an IgG1 mAb by Wei et al.43  Methionine oxidation to 
methionine sulfoxide in the Fc was also noted  by Liu et al.42 and Lam et al.41 for an IgG1 mAb 
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and the rhuMAb HER2, respectively.   Liu et al. observed oxidation of Met256 and Met432 
while studies by Lam et al. demonstrated oxidation initially occurring on Met255 followed by 
Met431 under extreme conditions.  Wei et al.43 identified Met255 and Met431 of an IgG1 mAb 
along with Met34, Met101 and Met361 of the heavy chain.  Similar to Qi et al. the studies by 
Wei et al. only identified a limited number of oxidized Trp residues, Trp54/55 and Trp105, albeit 
the heavy chains typically contain up to 15 Trp residues. 
More recently, studies by Mozziconnacci et al. focused on the photolytic degradation of 
disulfides of an IgG1 antibody.33  In those studies the mAb was photoirradiated with light at 254 
nm rather than the broad spectrum light noted in the previous studies.  They identified a series of 
dithiohemiacetal and thioether cross-links formed following photoirradiation and suggest the 
involvement of thiyl radicals in the processes.  Conceivably, an analogous process could occur 
following photolysis at 300 nm, as the photoionization of Trp would result in solvated electron 
formation leading to one electron reduction of disulfides to the thiyl radical and thiolate. 
Studies of the physical and conformational effects of photoirradiation on mAbs have been 
reported on a much more limited basis than the chemical degradation discussed above.  Qi et al.38 
showed that photoirradiation resulted in a pH dependent increase in yellowing of the mAb 
solution with yellow color noted in basic but not acidic conditions.  The mechanism of the 
yellowing was not defined.  In the same studies an increase in aggregation occurred in 
conjunction with increasing photoirradiation at pH 5.5.  The aggregates were nonreducible in 
nature which would be consistent with some of the mechanisms noted by Mozicconacci et al.33  
While changes in the fluorescence intensity with increasing photolysis were also noted, no 
changes in the conformation by either near or FAR-UV CD were discernible.  Similar effects of 
photolysis corresponding to an increase in aggregation were also reported by Maity et al.25 for 
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four different mAbs in phosphate buffered saline along with changes in the thermal unfolding 
profiles indicative of conformational change within the mAbs. 
Missing from these studies is a systematic analysis of the effects of pH and protein 
concentration on the conformation of a mAb following exposure to UV light typically used 
during the purification process.  Therefore, in this manuscript we studied the effect of pH and 
protein concentration on the conformational stability of a model IgG1 mAb during light exposure 
at 302 nm. The stability of the antibody was examined over a 100-fold range of concentrations 
from 0.1 mg/mL to 10 mg/mL as it is only until the final concentration steps where the antibody 
concentration is increased during the diafiltration step.  Here we demonstrate that conformation 
and aggregation are inversely correlated with pH in a concentration-dependent manner for 
aggregation but not conformation.  Aggregation resulted in covalent, non-reducible, crosslinks, 
consistent with some of the crosslinks suggested by Mozzicconacci et al.33 with samples at the 
highest pH showing the greatest degree of aggregation.  The aggregation may also be result of 
Cys-Lys crosslinks which have been proposed by Vanhooren, et al.45  At all pH’s examined, 
photolysis produced a decrease in the heat capacity of the mAb.  The conformational change was 
confirmed by changes in the heat induced denaturation/unfolding profile of Trp with samples 
irradiated at pH 3.5 showing multiple transitions during the thermal unfolding process.  The 
inverse pH dependence of the UV light induced conformational change to that of UV light 
induced aggregation suggests that different strategies will be required to stabilize the protein 
against these modifications during processing. 
Materials and Methods: 
Materials 
Anti-Streptavidin IgG1 mAb was obtained from Amgen Inc. at a concentration of 38.5 
mg/ml in 10mM sodium acetate, 9% Sucrose (w/v), pH 5.2.  The ferrioxalate actinometry 
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experiment used potassium oxalate 99% (Acros Organics, part # 424025000), ferric sulfate (MP 
Biomedicals, LLC, part # 158042) and 1, 10-phenantholine 99+% (Acros Organics, part # 
157530250).  Novex Tris-Glycine SDS Running Buffer (Invitrogen Life Sciences, part # 
LC2675) and Destain I (Teknova, part number D0010) were used for the gel electrophoresis. A 
Modified Lowry Protein Assay Kit (Pierce, part # 23240, Lot # Jl125160) was used to obtain the 
protein concentration.  To determine the extent of free sulfhydryls in the sample, 5,5’-dithio-
bis(2-nitrobenzoic acid) (DTNB) obtained from Invitrogen (part # D8451, Lot 532063 ) and N-
acetyl-L-cysteine (NAC) from Sigma (part # A 7250-5G, Lot # 118K0049) were used. 
Data Analysis 
Where specified, the following software packages were used for data analysis:  Microsoft 
Excel 2007, OriginPro version 8.0 (OriginLab Corporation), Sigma Plot version 11.0 (Systat 
Software, Inc.), Grams/AI version 9.0 R2 (Thermo Fisher Scientific Inc.). 
Sample preparation 
Anti-Streptavidin was determined to have a pI of 8.7 (Amgen internal data).  Initial work 
was conducted using solutions at 0.1 mg/mL anti-streptavidin to minimize protein-protein 
interactions and to aid in our understanding of the experimental system.  The stock anti-
streptavidin provided was used to prepare solutions at 0.1 mg/mL in 10 mM sodium acetate, pH 
3.5 and 5.0 by diluting the stock mAb solution into the corresponding buffer.  Similarly, 
solutions were prepared at 0.1 mg/ml in 10 mM sodium phosphate, pH 8.0.  These samples were 
exposed to 302nm light for either 30 or 60 minutes and compared to control samples protected 
from light.   
Subsequent experiments examined the higher mAb concentrations of 1.0 and 10 mg/mL 
for ease of analysis by biophysical analytical methods and the bulk of the analysis was done 
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using these samples.  Solutions were prepared at 1.0 and 10 mg/mL for the three separate buffer 
solutions, 10 mM sodium acetate pH 3.5 and 5.0, and 10 mM sodium phosphate pH 8.0.  The 
aliquots of the samples were then exposed to light as described below for 0, 1, 5, 15, 30, 45, and 
60 minutes. 
Aliquots of 400 and 800 µl were placed into quartz cuvettes under a UV lamp 10 cm 
distant from the lamps (UVPLMS-38 EL Series 3UV Lamp, part number 95-0252-01, serial 
number 010406-001) emitting 302 nm light with an intensity of 1.864 µW as measured with a 
Newport Optical Power Meter, model 840 with calibration module 818-ST/UV, Serial number 
242.  The photon flux incident to the samples was determined as vide infra.  The samples were 
exposed to ultraviolet light for the specified times described above, in a walk-in cold chamber 
regulated to 2-8ºC.  The control solutions of 0.1, 1.0, and 10 mg/ml anti-streptavidin in either 
10mM sodium acetate, pH 3.5 or 5.0 were kept at 2-8ºC protected from light.  Similarly, control 
solutions of 0.1, 1.0, and 10 mg/ml anti-streptavidin in either 10mM sodium phosphate, pH 8.0 
were also kept at 2-8ºC protected from light.  Samples were stored at 2-8ºC protected from light 
until analyzed.  The pH of all solutions was measured after exposure using a Thermo Orion pH 
meter with a Thermo Micro Combination pH electrode.   
Ferrioxalate Actinometry 
 Ferrioxalate actinometry46,47 was used to determine the photon flux incident on the 
samples exposed to 302 nm light by the UV lamp system described above.  As applied by Roy, 
S. et. al., all solutions were prepared fresh immediately prior to conducting this experiment.39  A 
0.2% (w/v) solution of 1,10-phenanthroline in water was prepared.  The actinometer buffer 
solution was also prepared by dissolving 82 g of sodium acetate along with 10 mL of 
concentrated sulfuric acid into 1 L of deionized water.  An additional solution of 0.2M ferric 
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sulfate containing 55mL of concentrated sulfuric acid and 100 g ferric sulfate (Fe2(SO4)3
.nH2O) 
was prepared to a final volume of 1 L in deionized water.  A final solution of 1.2 M potassium 
oxalate (K2C2O4) was also prepared in water.  All three solutions were prepared in aluminum foil 
wrapped bottles.  To conduct the experiment, 5 mL of the ferric sulfate was added to 5 L of the 
potassium oxalate solution in a volumetric flask wrapped in aluminum foil.  The mixture of ferric 
sulfate and potassium oxalate in the volumetric flask was then diluted to 100 mL with deionized 
water, in the dark to form a 0.02 M potassium ferrioxalate (K3Fe(C2O4)3) solution.  
Subsequently, 200 µL of 10 mM sodium acetate, pH 5.0 was mixed with 200 µL of the 
potassium ferrioxalate solution and placed into a quartz cuvette to be irradiated by 302 nm light 
under similar conditions as the sample experienced.  Upon irradiation, the reaction is as 
described in equation 1.  After irradiation, the sample was once again mixed and a 200 µL 
aliquot of it was taken and added to 400 µL of the 1,10-phenanathroline solution with 100 µL of 
the actinometer buffer.  The final volume was brought to 2 mL by the addition of 1.3 mL of 
deionized water.   The absorbance of this solution was measured at 510 nm allowing for the 
determination of the molar concentration of the ferrous-phenanthroline complex using an 
extinction coefficient of 1.11 x 104 M cm-1 after using the appropriate dilution factor.  Using 
Avogadro’s number (6.023 x 1023 molecules/M), the number of molecules of the complex could 
be determined.  Once that was accomplished for each of the exposure times in triplicate, a plot of 
the molecules of the complex versus exposure time could be obtained allowing for the rate of 
formation (dn/dt) to be determined.  Along with the quantum yield of Φ(λ) = 1.24 at 302 nm for 
a 0.02 M ferrioxalate solution, the photon flux was determined using equation 2 where 
Pa,λ represents the rate of photons absorbed by the system at λ (photons s-1). 
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(1)                        Fe3+ + C2O42-      
hυ         2Fe2+ + 2CO2 
 
(2)     (dn/dt) = Φ(λ)/Pa,λ  
 
Modified Lowry Protein Assay 
The protein concentration was also determined using the Modified Lowry Protein Assay 
Kit.  A standard curve of known concentrations of anti-streptavidin was prepared according to 
the kit instructions.  200 µl of each standard concentration was aliquoted in triplicate and treated 
as individual samples along with 200 µl of each unknown anti-streptavidin sample.  To each 
sample, 1ml of Modified Lowry Reagent was added followed by mixing and incubation at room 
temperature for exactly 10 minutes.  After 10 minutes, 100 µl of 1x Folin-Ciocalteu Reagent was 
added to each sample followed by vortexing.  All samples were allowed to incubate in the dark at 
room temperature for 30 minutes at which point the absorbance was measured at 750 nm against 
a water blank.   
The modified Lowry Protein Assay was used to determine the protein concentration of 
the 1mg/ml anti-streptavidin samples used in the above assays.  In all cases, the protein 
concentration was determined to be 1.04 +/- 0.05 mg/mL 
Size Exclusion HPLC/ Size Exclusion MALS 
Size exclusion HPLC was performed using an Agilent 1100 HPLC with an isocratic flow 
rate of 0.5 mL per minute.  The mobile phase consisted of 100mM Sodium Phosphate, 250 mM 
Sodium Chloride, pH 6.8 at 25.0ºC.  The column, purchased from Tosohaas, was a TSKgel 
G3000SWXL, 7.8 mm ID x 30 cm, 5 µm, column # N6825-10N, part number 08541 maintained 
at 25ºC for the duration of the 30 minute analysis time.  Detection was achieved at 214 nm and 
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280 nm, with the 214 nm signal used for integration.  A 100 µl injection for a target column load 
of 10 µg of anti-streptavidin was used for the 0.1 mg/mL concentration.  For the higher 
concentrations of 1 mg/mL and 10 mg/mL anti-streptavidin, a target column load of 40 µg of the 
antibody was injected at the start of each analysis.  Simple integration of the peak areas was 
conducted in order to calculate percent area of the peaks.  The areas for peaks eluting before the 
main peak were summed and referred to as high molecular weight (HMW) peaks.  Likewise, 
peaks eluting after the main peak were also summed and labeled as low molecular weight 
(LMW) species.  Plots of the percent main peak, percent high molecular weight and percent low 
molecular weight were made as a function of exposure time. 
For size exclusion HPLC with multi-angle light scattering (MALS) detection, the method 
described above was coupled to a MALS system with the exception that the load of 
antistreptavidin was increased to 100 µg for both the 1 mg/mL and 10 mg/mL samples to 
maximize signal intensity.  Due to the limitation of detection for the MALS system, 0.1 mg/mL 
was not analyzed.  Post UV detection, a Wyatt QELS Dawn EOS light scattering detector using a 
laser wavelength of 690.0 nm was added to the flow path and interfaced with an Optilab rEX 
refractive index detector in series.  A refractive index of 1.3194 was used to adjust for the mobile 
phase.  Immediately prior to the measurement of the samples, the system was calibrated using a 
known BSA (bovine serum albumin) solution. 
Gel Electrophoresis 
Samples of anti-streptavidin at 1 mg/mL were analyzed by SDS-PAGE with silver 
staining.  Unexposed material was studied as well as material exposed to 302 nm for 15 and 60 
minutes at pH 3.5, 5.0 and 8.0.  Prior to analysis, aliquots of all samples were diluted with either 
1.1 X non-reducing sample buffer or 1.1 X reducing sample buffer.  The 1.1 X non-reducing 
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sample buffer consisted of 68.89 mM Tris HCl pH 7.0, 2.2% SDS, 0.044% bromophenol blue, 
and 22.22% glycerol.  The 1.1 X reducing sample buffer consisted of 68.89 mM Tris HCl pH 
7.0, 2.2% SDS, 0.044% bromophenol blue, 22.22% glycerol, and 111.11 mM dithiothreitol.  For 
both the non-reducing and reducing conditions, the samples were incubated at 60ºC for 10 
minutes in a water bath to denature and in the case of reducing conditions, to also reduce all 
disulfide linkages of the protein.  After incubation, 10 µL of each sample was placed into 
individual wells of a Novex 4-20% tris-glycine 1.0 mm x 10 well gel (Invitrogen Life Sciences, 
part # EC6025BOX).  The gels were developed using Novex Tris-glycine SDS running buffer 
(Invitrogen Life Sciences, part # LC2675) and a Powerease 500 ((Invitrogen Life Sciences, part 
# EI8600) until the bromophenol blue marker reached the bottom of the gel.  Once the sample 
had finished separating, both the non-reduced and reduced gels were subjected to silver staining 
as described below.  Each gel was separately soaked in 50% (v/v) ethanol for 5 to 7 minutes to 
dehydrate the gel.  The gels were then immediately placed into 20% (v/v) ethanol for at least 20 
minutes but no longer than 2 hours at room temperature, after which the development process 
was began.  First, the gels were independently placed into 0.02% sodium thiosulfate for 1 minute 
followed by twice rinsing with deionized water.  The gels were then placed into a silver staining 
solution containing 2 g of silver nitrate and 750 µL of formaldehyde in water for 20 to 60 
minutes.  The gels were then washed two times with deionized water and then placed for 2-3 
minutes into a developer solution comprised of 60 g sodium carbonate, 500 µL formaldehyde 
and 200 µL of 2% (wt/vol.) sodium thiosulfate in 1 L of deionized water.  Once the bands 
became visible, the developer solution was discarded and Destain I (Teknova, part number 
D0010) or 45% methanol and 9% acetic acid was added to stop over development of the gel.  
 15
The gels were allowed to soak for a minimum of 10 minutes followed by a final rinse with 
deionized water.  The gels were then photographed and dried. 
Differential Scanning Calorimetry 
 A MicroCal Capillary Cell MicroCalorimeter, Model VP-DSC, was used to analyze 1mL 
aliquots of 1 mg/mL anti-streptavidin exposed for 15 and 30 minutes at pH 3.5, 5.0 and 8.0 as 
described above.  Control samples of unexposed material at the same pH’s were also evaluated.  
The reference cell contained only the sample buffer.  The autosampler was maintained at 25ºC.  
The scan rate was 1ºC per minute with a starting temperature of 15ºC and an ending temperature 
of 95ºC.  Upon completion of the first scan, a second scan was immediately conducted to 
examine the extent of reversibility for each sample.  The resulting thermograms were analyzed 
using OriginPro software by fitting a baseline and obtaining the Tms. 
Intrinsic Tryptophan Fluorescence of Heat Induced Denaturation of Anti-streptavidin 
Fluorescence emission scan measurements were made using a PTI Fluorimeter, model 
814.  Three samples were prepared at a concentration of 0.1 mg/mL, one sample was in 10 mM 
sodium acetate pH 3.5, the second sample as in 10 mM sodium acetate, pH 5.0, and the third 
sample was in 10 mM sodium phosphate, pH 8.0.  All samples were analyzed in triplicate (n=3).  
A Hellma quartz cuvette with a magnetic stirrer having a pathlength of 10 mm was used (part 
number 119.000F-QS).  An excitation wavelength of 295nm was used with an excitation slit set 
to 0.50 mm.  The emission spectrum was scanned from 300 to 450 nm with an emission slit 
width of 0.5 mm.  The fluorimeter was fitted with a single cell peltier controlled cuvette holder 
(Quantum Northwest, TC 125).  Measurements were made every 5ºC from 10ºC to 95ºC.  
Heating rate was 1ºC/minute with an equilibration time of 3 minutes.   The raw data were 
exported to Microsoft Excel and SigmaPlot for graphing using the average and standard 
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deviation of the three individual analyses.  The fluorescence intensity of the corresponding buffer 
was subtracted from the sample intensity for each sample individually. 
To generate the fluorescence peak maximum versus temperature graphs, the data was 
exported into Origin, version 8.0 allowing the first derivative to be generated for each sample.  
The data was then plotted and fit to a quadratic equation using Microsoft Excel allowing the 
calculation of the peak maximum.  The peak maximum was then simply plotted as a function of 
temperature.  To obtain melting temperature (Tm) values, the maximum and minimum peak 
positions were subtracted from each other, the value divided by two and added back to the 
minimum value.  Using the graph of fluorescence peak maximum (Fmax) versus temperature, the 
Tm could then be determined. 
Intrinsic Tryptophan Fluorescence 
 Samples of anti-streptavidin at both 1.0 mg/ml and 10.0 mg/mL were exposed to 302 nm 
UV light at 4ºC for 0, 1, 5, 15, 30, 45, and 60 minutes.  Three separate buffer solutions were 
examined:  10 mM sodium acetate, pH 3.5, 10 mM sodium acetate, pH 5.0, and 10 mM sodium 
acetate, pH 8.0.  The intrinsic fluorescence of the samples was monitored at 25ºC using a PTI 
Fluorimeter, model 814.  The sample was excited at 295 nm with both the excitation and 
emission slits set to 0.5 mm.  For the low concentration of 1.0 mg/mL anti-streptavidin, a Hellma 
(part number 105.251 QS) quartz cuvette with a pathlength of 3 mm was used.  For the higher 
concentration of 10 mg/mL anti-streptavidin, a Hellma (part number 105.252-QS) quartz cuvette 
with a pathlength of 1.5 mm was used.  The data were exported and plotted in SigmaPlot. 
Near UV Circular Dichroism 
Near UV circular dichroism measurements were made for the 10 mg/mL, 1.0 mg/mL and 
0.1 mg/mL anti-streptavidin solutions described above using quartz Hellma cells with path 
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length of 0.01, 0.10 and 1.00 cm (part numbers 106-0.01-40, 106-0.10-40, and  110-QS).  All CD 
measurements were made averaging 3 scans using a Jasco J-810-150S spectropolarimeter at 
25ºC set with a response time of 16 seconds, data pitch of 1 nm, and a scanning speed of 
20nm/min.  Each sample was scanned from 350 to 250 nm.  The 1 mg/mL and 10 mg/mL 
samples were analyzed in triplicate.  For all samples, the data were exported into an Excel 
spreadsheet where the buffer scan was subtracted from the individual sample signals (n=3).  The 
mean residue ellipticies (MRE, deg cm2/dmole) were calculated using equation (3), where M0 is 
the mean residue weight (107.57 Da/residue), Θ is the observed ellipticity (mdeg), l is the light 
path, and c is the concentration (mg/mL).36  The average of the MRE (n=3) was calculated using 
Excel.  The data were then exported and the average MRE was graphed using SigmaPlot. 
 
(3)   MRE = M      
       
 
 
2nd Derivative Ultraviolet-visible Spectroscopy 
Samples of anti-streptavidin at both 1.0 mg/ml and 10.0 mg/mL were exposed to 302 nm 
UV light at 4ºC for 0, 1, 5, 15, 30, 45, and 60 minutes at pH values of 3.5, 5.0 and 8.0.  UV-vis 
absorbance measurements were made using aliquots of the sample in a Hellma quartz cell with a 
1 mm path length (110-QS, 1 mm) and an Agilent 8453 UV-vis spectrometer blanked against the 
sample buffer dependent upon the pH of the sample.  Anti-Streptavidin was determined to have 
molar extinction coefficient of 1.586 mL × mg-1 × cm-1 (Amgen internal data).  The spectrometer 
integration was set to 25 seconds with an interval of 1 nm.  Data analysis was begun using 
Agilent’s UV-Vis ChemStation software by taking the second derivative of the absorbance A 
(d2A/dλ2) using a nine point data filter with a third-order Savitzky-Golay polynomial fit.  A 
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spline function using 50 interpolated points between each raw data point was then applied to the 
resulting spectra such that the resolution was 0.02 nm.48  The data were then exported to 
OriginPro for peak assignment and plotting. 
Far UV Circular Dichroism 
Far UV circular dichroism using quartz Hellma cells (part number 110-QS, 1mm and 
106-0.10-40) having a path length of 1.0 and 0.10 mm were made for both the 1.0 mg/mL and 10 
mg/mL anti-streptavidin solutions described above.  All CD measurements were made averaging 
3 scans using a Jasco J-810-150S spectropolarimeter at 25ºC set with a response time of 16 
seconds, data pitch of 1 nm, and a scanning speed of 20 nm/min.  Each sample was scanned from 
250 to 190 nm.  All samples were analyzed in triplicate.  Excel was used to subtract the signal of 
the sample buffer from the signal for the individual samples as well as to calculate the MRE and 
its average value (n=3).  SigmaPlot was used to plot the average MRE data.  
FTIR spectroscopy 
Infrared spectra were collected for the 10 mg/mL anti-streptavidin samples using an ABB 
Bomem (Que., Canada) MB Series FTIR spectrometer.  The data were collected using a Biocell 
obtained from Bio Tools, Inc (part number BCT1006, serial number SPS2009_08) having a fixed 
pathlength of 6.2 µm.  Each spectrum was obtained by collecting 128-scan interferograms in a 
single-beam mode having 4 cm-1 resolution.  Reference scans containing only the buffer were 
made for each of the pH conditions to be used later for subtraction from the corresponding pH 
samples to yield that of just the protein under each condition.  For confirmation purposes, FTIR 
spectra for each of the conditions studied at 10 mg/mL and 1 mg/mL were also recorded at room 
temperature using a Bruker Vertex 70 Fourier transform infrared spectrometer, equipped with an 
MCT detector.  The samples were measured directly in the AquaSpec Cell that employs CaF2 
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windows separated by a 6 μm spacer.  For each spectrum, a 256-scan interferogram was 
collected in a single beam mode, with a 4 cm-1 resolution.  Reference spectra were recorded 
under identical conditions with the corresponding buffer in the cell.  The reference spectra for the 
buffer blank were subtracted from the protein spectra.  Regardless of the instrument used, once 
the protein spectra were obtained they were subjected to second derivative analysis using a 
Savitsky-Golay derivative function followed by baseline correction and normalization and finally 
plotted using SigmaPlot software.  Data obtained using the Bruker instrument is reported here.49-
52 
Ellman’s Test for free sulfhydryls 
Immediately prior to analysis, a 4 mM DTNB solution in 50 mM Tris HCl, pH 8.0 and 8 
M Guanidine HCl was prepared.  At the same time a stock solution of N-acetyl-L-cysteine 
(NAC) was also prepared to a final concentration of 2 mM NAC and 25 mM Tris HCl, pH 8.0 in 
deionized water and used within 30 minutes.  From the stock NAC solution, NAC standards 
were prepared to a final concentration of 0, 4, 8, 12, 16, 20, 28, and 40 nMols in Tris HCl pH 8 
and 8 M guanidine HCl.  The standards were incubated with 216 µl Ellman's reagent 
(approximately 3.37 mM 5,5’-dithio-bis(2-nitrobenzoic acid (DTNB)) in the dark for 15 minutes.  
Again, at the same time, samples protected from light of 10 mg/mL of anti streptavidin in 10 mM 
sodium acetate at pH 3.5 and 5.0 as well as 10 mM sodium phosphate, pH 8.0 were compared to 
samples exposed to 302 nm light for 30 minutes.  All samples were prepared in triplicate by 
taking 40 µl 1 M Tris HCl, pH 8.0, 0.696 µl 8 M GuHCl, and 200 µL of the sample and 
incubating it with 11.4 µl Ellman's reagent (4 mM DTNB) in the dark for 15 minutes.  The 
absorbance of all solutions at 412nm was immediately measured using an Agilent 8453 UV-vis 
spectrometer blanked against the sample buffer with DTNB.  Using the standard curve plotted 
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using Microsoft Excel, the obtained equation from a linear fit of the data, the absorbance of each 
sample, and the number of cysteines in the primary structure of anti streptavidin at 32, the % free 
sulfhydryls was obtained. 
Results: 
 All samples were visually inspected prior to analysis.  Under the conditions studied, no 
precipitation of anti-streptavidin was observed.  Using ferrioxalate actinometry, it was 
determined that the samples were exposed to an incidence photon flux of 16.32 x 1020 photons/s 
(1074.20 J/s).  Based on the Modified Lowry Protein Assay, no substantial loss of protein was 
observed upon exposure to ultraviolet light. 
Effect of light on aggregation 
 Following exposure to 302nm light for 0, 1, 5, 15, 30, 45, and 60 minutes, the samples 
were analyzed by size exclusion (SEC) HPLC.  The chromatograms showed several important 
differences where the most dramatic difference was caused by pH of the sample.  At pH 3.5, the 
loss of the main peak was accompanied by an increase in an earlier eluting peak at approximately 
13.5 minutes (Figure 1).  The main peak also broadened upon light exposure.  At pH 5.0, the 
main peak also broadened upon light exposure, but to a smaller extent; in addition, we observed 
a concomitant formation not only of the earlier eluting peak at 13.5 minutes, but also an 
additional peak eluting at 12.5 minutes.  For the pH 8.0 samples, a growth of the peaks at 13.5 
and 12.5 minutes was observed as well as earlier eluting peaks at approximately 11.5 and 10.0 






Figure 1.  Size Exclusion HPLC MALS for 1 mg/mL anti-streptavidin.  The right vertical axis 
labeled as Differential Refractive Index shows the change in refractive index as a function of the 
retention time producing a typical chromatogram as the sample elutes.  The left vertical axis 
labeled as Molar Mass (g/mol) is associated with the short lines under the main peak of the 
chromatogram and the short lines above the high molecular weight species indicating the molar 
mass of the species at the same retention time.  
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For all conditions examined, growth in earlier eluting peaks along with broadening of the 
main peak could be observed in as short as 1 minute of exposure to 302nm light.  These 
differences were not accounted for by storage of anti-streptavidin at the solution conditions 
examined as anti-streptavidin was found to be stable in non-irradiated control solutions during 
the analysis time (data not shown).  To examine if a pH-shift alone following photolysis could 
account for the increased aggregation as compared to that observed at pH 3.5, an experiment was 
conducted in which a 1 mg/mL sample in 10mM sodium acetate, pH 3.5 was exposed to 302 nm 
light and then diluted into 10 mM sodium phosphate, pH 8.  The results in Figure 1 show that 
samples exposed to light at pH 8.0 should have a greater extent of high molecular weight 
(HMW) aggregates than those at pH 3.5.  Yet, it was observed that the sample irradiated at pH 
3.5 followed by shifting the pH to 8.0 showed a similar amount of HMW aggregates as that 
observed for the pH 3.5 sample that was exposed to the light and not diluted (data not shown).  
This observation indicated that the formation of aggregates during photolysis is dependent upon 
the pH of the solution.  Adjusting the pH after photolysis did not result in an increase in 
aggregates. 
From the sequence of anti-streptavidin, the molecular weight of the mAb monomer was 
determined to be 142,159.5 Da.  Analysis by SEC MALS of the 1 mg/mL samples exposed to 
302 nm light for 60 minutes demonstrated that a species having approximately the same mass as 
a dimer was the predominate species formed at all three pH’s.  At pH 5.0, in addition to dimer 
formation, a trimer was also observed, while at pH 8.0 additional HMW species including 
tetramer and other larger species were seen.  The 10 mg/mL data was similar to the 1 mg/mL 
data and therefore for ease of explanation is not shown. 
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To further illustrate the differences in rates of aggregation with pH and protein 
concentration the percent HMW species was plotted against the duration of light exposure (see 
Figure 2).  At pH 3.5 no change was observed in the concentration of HMW species over a 60 
minute exposure time while a slight increase was observed at the same pH with increasing 
protein in the order of 0.1 mg/mL < 1 mg/mL < 10 mg/mL.  In contrast, aggregation increased at 
all protein concentrations during exposure at pH 5 and pH 8 with the increase at pH 8 greater 
than that at pH 5.  Across the protein concentrations distinct differences were seen in the 
aggregation rates with the 10 mg/mL samples showing a linear increase and the 0.1 and 1 mg/mL 
showing a faster phase for the initial time points followed by a shallower linear increase over the 
remaining time period.  While an increase in the low molecular weight species can also be 
discerned by SEC analysis, the data is not reported here because of the complexity in the 
interpretation due to disulfide bond formation and non-covalent interactions between the heavy 














































































W, loss of m
raphs A to 
creasing exp
Graphs D-F
e for 0.1 (G








C show the 
osure time 



























































 10 mg/mL 
ation of the 
ph A), 1.0 (G
se in the per

























Evaluation of the non-reduced SDS-PAGE  reveals the expected growth in aggregation 
(Figure 3) that is observed by SE HPLC.  For reference purposes, a molecular weight ladder was 
loaded in the first well of each gel ( lane 1).  Unexposed samples were loaded into lanes 2, 5, and 
8 for pH 3.5, 5.0, and 8.0 respectively.  Samples exposed to 302 nm for 15 minutes were loaded 
into lanes 3, 6, and 9 for pH 3.5, 5.0, and 8.0 respectively.  Similarly, samples exposed to 302nm 
for 30 minutes were loaded into lanes 4, 7, and 10 for pH 3.5, 5.0, and 8.0 respectively.  From 
the amino acid sequence, the heavy chain has a molecular weight of approximately 48 kDa 
without glycosylation while the light chain has a molecular weight of approximately 23 kDa and 
does not have a glycosylation site.  The band slightly below the intact anti-streptavidin band is 
likely a form of the antibody that is missing a single light chain and can be observed in the non-
reduced gel for all samples.  A fairly dark band in the non-reduced gel associated with the light 
chain is also readily noticeable.  Both the mAb missing a light chain as well as the light chain 
only are likely carryover from the purification process as they are in all of the unexposed 
samples.  Most apparent is the appearance of multiple bands above the heavy chain band having 
high molecular weights.  These bands appear to be more intense upon longer exposure time.  
This holds for all three pH’s and is in good agreement with that observed in the size exclusion 
HPLC data.  The number of bands and the intensity also appear to increase with increasing pH.  
There was also observed an increase in lower molecular weight material between 36.5 and 55.4 
kDa upon exposure to 302 nm light.  The presence of these low molecular weight species 




Figure 3.  SDS-PAGE silver stained of 1 mg/mL anti-streptavidin exposed up to 30 minutes to 
light at 302nm in three different buffer systems, both reduced and non-reduced gels.  Lane 1 
molecular weight ladder (kDa), Lane 2 pH 3.5 unexposed, Lane 3 pH 3.5 exposed 15 minutes, 
Lane 4 pH 3.5 exposed 30 minutes, Lane 5 pH 5.0 unexposed, Lane 6 pH 5.0 exposed 15 
minutes, Lane 7 pH 5.0 exposed 30 minutes, Lane 8 pH 8.0 unexposed, Lane 9 pH 8.0 exposed 
15 minutes, Lane 10 pH 8.0 exposed 30 minutes. 
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The reduced SDS-PAGE gel on the left-hand side of Figure 3 clearly shows the heavy 
and light chains for anti-streptavidin.  Most noticeable in comparison to the non-reduced gels, 
high molecular weight bands remain demonstrating the presence of non-reducible aggregates in 
all exposed samples.  The increase in the high molecular weight species, trends with increasing 
pH and exposure time.  The longer the exposure time, the more intense the high molecular 
weight bands become.  Again, similar to the size exclusion data, there is an increase in the 
number of aggregate bands with increasing pH.  A comparison with the molecular weight 
markers, provides a crude estimation of the bands molecular weights and suggests the growth of 
dimer, trimer, and higher order oligomer species with increasing exposure times.  There is also a 
corresponding growth in low molecular weight clip species.  This indicates that along with non-
reducible aggregates, there are also a variety of reducible species having molecular weights of 
less than that of the intact antibody, intact heavy chain as well as the intact light chain.  These 
species can be observed below the molecular weight of the intact antibody, intact heavy chain 
and intact light chain.  The new bands can be observed most readily for the pH 3.5 exposed 
samples.  Specifically for pH 3.5 exposed samples, there can be seen several new clip species 
smaller than the light chain.  There are also a series of new bands between 23 to 48 kDa that 
become darker with increasing exposure time and decreasing pH.  For pH 5.0 and 8.0, the 
clipping is most apparent by the appearance of bands between the heavy and light chains, 
although there also appears to be growth in a species having a molecular weight less than that of 
the light chain for all three pH’s. 
Effect of light on conformation 
The conformation of the anti-streptavidin mAb was assessed using multiple biophysicial 
techniques in combination with thermal stress following photoirradiation.  The thermal stability 
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by DSC was examined by collecting thermograms of 1 mg/mL anti streptavidin unexposed and 
then exposed for 15 and 30 minutes for each of the three pHs (see Fig. 4).  Under the conditions 
studied, the thermal unfolding of anti-streptavidin was irreversible likely as a result of aggregate 
formation.  As a result equilibrium thermodynamics could not be used to obtain accurate 
thermodynamic parameters.25  Despite this limitation, DSC and fluorescence measurements 
allowed for a number of observations to be made.  Three to four distinct unfolding transitions are 
observed for all thermograms, and in general are considered to be apparent melting transitions.  
These transitions have not been specifically assigned for this antibody so their exact identity 
remains unknown at this point.  For reference purposes, typically the first melting transition is 
assigned as either the CH2 domain or the Fab, with the third peak being assigned as the CH3 
domain.25,53  Whether or not this holds for this antibody, it can still be observed from an overlay 
of the three unexposed samples that there is clearly a shift towards higher temperatures with 
increasing pH, going from approximately 65°C for pH 3.5 to 72°C for pH 8 for the first 
unfolding transition.  Under all three buffer conditions, upon exposure to UV light, the unfolding 
transitions appear to become broader, indicating the presence of unfolding intermediates, 
although there does not appear to be any significant shift in the Tm values.  The trend becomes 
more pronounced with increasing exposure times such that a 30 minute exposure shows a 
dramatic broadening of the three transition peaks.  The trend for broadening of the apparent 
melting transitions also becomes more apparent at higher pH’s.  
Investigation of the tertiary structure by intrinsic fluorescence was performed for all three 
buffer systems at 0.1 mg/mL, 1 mg/mL or 10 mg/mL (not shown) anti streptavidin (see Figures 5 
and 6).  The intrinsic fluorescence during heating following photolysis was further used to 




Figure 4.  Differential scanning calorimetry thermograms of 1 mg/mL of anti streptavidin in 10 
mM sodium acetate pH 3.5 (Graph A), 10mM sodium acetate (Graph B), 10 mM sodium 
phosphate pH 8.0 (Graph C) exposed to 302nm light from 0, 15, and 30 minutes.  Comparison of 
differential scanning calorimetry thermograms of 1 mg/mL of anti streptavidin in 10 mM sodium 
acetate pH 3.5 and 5.0 and 10 mM sodium phosphate pH 8.0 is shown in the lower right panel 
(Graph D).  All thermograms were baseline corrected using the corresponding buffer 
thermogram.  (        pH 3.5,       pH 5.0,        pH 8.0) 
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Plots of the Fmax versus temperature showed that there was little to no shifts in the 
fluorescence peak position for the unexposed material up to 60ºC with a red shift in the Fmax 
during the unfolding transition.  The final Fmax attained for each pH showed a decrease with 
increasing pH from 348 nm at pH 3.5 to 346 nm at pH 5 and 343 nm at pH 8.  The midpoints of 
the transitions were 66 ºC for pH 3.5 and 70.5 ºC for pH 5 and 72.0 for pH 8 in agreement with 
the DSC data obtained for each of the samples.  In all cases, upon exposure to 302 nm light for 
60 minutes, there is a significant broadening of the transition as observed by an earlier red shift 
in the peak position, typically by as much as 20ºC before that observed for the unexposed 
material.  Again, the pH 3.5 sample exposed for 60 minutes showed the lowest midpoint of the 
transition value of approximately 58ºC, while pH 5.0 had a value of 62ºC.  The pH 8.0 sample 
exposed for 60 minutes had a value of approximately 60ºC.  The onset of the thermal transitions 
was also affected by pH with the pH 3.5 sample deviating from baseline at approximately 35 ºC 
and showing a multiphasic transition through the thermal unfolding process.  Material exposed at 
pH 5.0 also demonstrated a multiphasic transition with a deviation from baseline initiating at 
approximately 45 ºC.  Like the pH 5.0 exposed samples, the mAb exposed at pH 8.0 showed a 
deviation from baseline beginning at 45ºC and demonstrating an unfolding curve with a shape 
similar to a cooperative transition.  The final Fmax increased from the control sample by almost 1 
nm with a final value of 344.0 nm.  The fluorescence intensity of 1 mg/mL anti streptavidin at 
25ºC following increasing light exposure times at pH 3.5 and pH 5.0, and pH 8.0 was monitored 
using an excitation of 295 nm.  Figure 6.  A decrease in peak intensity up to 38 % of the original 





Figure 6.  Intrinsic fluorescence at 25 °C of buffer subtracted 1 mg/mL anti streptavidin in 10 
mM sodium acetate pH 3.5 (Graph A), 10mM sodium acetate pH 5.0 (Graph B), and 10 mM 









































































An examination of the tertiary structure by Near UV CD revealed changes in the spectra 
obtained for the 1 mg/mL pH 3.5 solution exposed for 60 minutes to 302 nm light as compared 
to that of unexposed material, but failed to show significant differences at 10 mg/mL  (see Figure 
7).  At pH 5, the averaged spectra of the UV-exposed mAb are identical to that of the unexposed 
mAb for both the 1 and 10 mg/mL solutions.  At pH 8, the spectra obtained after UV-exposure of 
1 mg/mL mAb show a decrease in the peak at approximately 295 nm associated with tryptophan 
residues when compared to the spectra of unexposed mAb.  This however was not seen in the 10 
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The effect of light exposure on the secondary structure of the protein was examined using 
both CD and FTIR spectroscopy.  Interrogation of the secondary structure by Far UV CD shows 
distinct differences between the unexposed sample and samples exposed up to 60 minutes with 
302 nm light (Figures 8 and 9).  The differences observed in the secondary structure are related 
to both the pH of the protein solution and to the concentration of the protein.  For all samples the 
structure is dominated by an intense negative band between 210-220 nm reflecting the β-sheet 
structure of anti-streptavidin.  At 0.1 mg/mL several trends can be noted.  There is a decrease in 
ellipticity in the region from 195 – 205 nm which suggests that there is an increase in random 
coil upon exposure to light.  At pH 3.5, the signal at 215-220 nm becomes more negative with 
increasing exposure time, while at pH 5 and 8 the signal becomes more positive.  At 1 mg/mL 
the pH 3.5 sample exposed for 60 minutes is dramatically different having a much more negative 
peak between 215 nm-220 nm which was similar to that observed for the 0.1 mg/mL time course 
experiment.  The pH 5 condition showed no change, while the pH 8 sample also showed a 
decrease in the 215-220 nm signal.  At the highest concentration of 10 mg/mL, the trend once 
again shows the pH 3.5 signal becoming more negative at 215-220 nm while the pH 5 and 8 both 
show an increase in the same region.  The changes in the negative band at 215-220 nm minimally 
indicate an alteration of the β-sheet structure with the trend to more positive values representing 
loss of β-sheet structure and a concomitant increase in random coil.  Differences in the Far UV 
CD signals upon aggregation of light exposed anti-streptavidin may also be accounted for by 
absorption flattening.  Absorption flattening occurs because of different light paths through the 






Figure 8.  Far UV CD of buffer subtracted 0.1 mg/mL anti streptavidin in 10mM sodium acetate 
pH 3.5 (Graph A), 10mM sodium acetate pH 5.0 (Graph B), and 10mM sodium phosphate pH 
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Examination of the amide I region of the FT-IR spectrum using second derivative 
analysis shows that the anti-streptavidin spectrum is dominated by bands at approximately 1690 
and 1639 cm-1 frequently associated with β-sheet structure.50,56  The FT-IR spectra were 
collected for both the 1 mg/mL and 10 mg/mL samples, though for simplicity of discussion, only 
the 10 mg/mL data is shown here (Figure 10).  No concentration effect was observed.  In general, 
there are a number of additional bands between 1660 to 1680 cm-1.  These bands have been 
assigned to turns in the secondary structure.50,56  One additional band is observed at 
approximately 1615 cm-1 and is considered to be associated with intermolecular β-sheet structure 
structures.  Interestingly, FTIR analysis for the 10 mg/mL anti streptavidin in 10mM sodium 
acetate, pH 3.5 showed the most dramatic difference upon exposure for 60 minutes at 302nm, 
primarily in the region of 1660 to 1680 cm-1 where the structure is dominated by turns.  
However, there is also some difference in the signal at 1615 cm-1.  The anti streptavidin in 10mM 
sodium phosphate pH 8.0 showed very little difference in the secondary structure while the pH 





Figure 10.  FTIR of 10 mg/mL of anti streptavidin in 10mM sodium acetate pH 3.5 (Graph A), 
10 mM sodium acetate pH 5.0 (Graph B), 10 mM sodium phosphate pH 8.0 (Graph C) exposed 
to 302nm light from 0, 15, and 30 minutes.  (        unexposed,         exposed).  Comparison of 
FTIR of 10mg/mL of anti streptavidin in 10mM sodium acetate pH 3.5 and 5.0 and 10 mM 
sodium phosphate pH 8.0 is shown in the lower right panel Graph D.  Data obtained using a 
































































































Ellman’s Test for free sulfhydryl groups 
A simple Ellman’s test for free sulfhydryl groups showed that the starting, unexposed 
material contained little to no free sulfhydryl groups (data not shown).  After exposure to 302 nm 
light, the free sulfhydryl content of the samples remained below the limit of detection. 
Discussion: 
 In the studies presented here we examined the effects of pH and protein concentration on 
the stability of an IgG1 mAb following exposure to UV light at a wavelength representative to 
what may be experienced during the purification process.  We examined three separate pH 
conditions, pH 3.5, 5.0 and 8.0, at three separate antibody concentrations ranging from dilute 
solutions of 0.1 mg/mL to 10 mg/mL.  These solutions were exposed to 302 nm light for up to 60 
minutes and then analyzed by a variety of techniques monitoring physical and conformational 
stability.  Based on size exclusion HPLC and SDS-PAGE data we conclude that there is a pH 
and concentration dependence on the rate of aggregation upon light exposure.  The amount of 
aggregation increased with increasing pH.  Interestingly, non-reducible aggregates were 
observed upon exposure to 302 nm light.  A pH dependence was observed where pH 8.0 showed 
the greatest extent of non-reducible aggregates, the trend being pH 3.5 < pH 5.0 < pH 8.0.  
Examination of the thermal properties of these solutions showed that the apparent melting 
transitions decreased with decreasing pH.  At all three pH values studied, the apparent melting 
transitions became broader upon light exposure, with the lowest temperatures being observed for 
the lowest pH.  In contrast to the trend for aggregation, the conformational stability revealed the 
greatest changes in the secondary structure at pH 3.5 upon light exposure and followed the trend 
of pH 3.5 > pH 5.0 > pH 8.0.  
 As noted above, upon exposure to light at 302 nm, anti streptavidin experienced a number 
of negative consequences.  Predominately, the formation of aggregates is both time and pH 
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dependent.  Perhaps not surprisingly, the longer the UV-exposure, the more aggregates are 
observed.  This trend of increasing aggregation upon increasing exposure times to UV light has 
been well documented by others.38,39,43  As mentioned, anti streptavidin forms predominately 
soluble non-reducible aggregates under conditions studied here.  This is in contrast to the 
observations made with sTNF-R1.24  Like anti-streptavidin, sTNF-R1 predominately has a β-
sheet structure and contains a large number of disulfide bonds.  However, unlike anti-
streptavidin, sTNF-R1 showed primarily reducible aggregation upon exposure to 302nm light.  
Roy et. al. reported that sTNF-R1, under similar conditions, underwent tryptophan-mediated 
formation of intermolecular disulfide cross links.39  Anti-streptavidin appears to form covalently 
linked, non-reducible aggregates and therefore its aggregation must proceed through a different 
mechanism.   
Recently, Mozzacionacci et. al. demonstrated that exposure to 254 nm light lead to the 
formation of dithiohemiacetal and thioether cross-links.33  Such products are potential candidates 
also for our experimental conditions (302 nm light) but must await further characterization.  
While this has yet to be demonstrated as the pathway that anti-streptavidin is following, it seems 
likely that this is the case given the non-reducible nature of the aggregates produced by exposure 
of anti-streptavidin to 302nm light.  The negative test for free sulfhydryls would lend support to 
this mechanism. 
Effect of light on conformation of the anti-streptavidin mAb 
To understand the impact of light exposure on anti-streptavidin and help define the 
mechanism behind the pH dependence of the observed aggregation we studied the conformation 
of the mAb before and after exposure to 302 nm light.  One of the first experiments conducted 
was to examine the thermal stability of anti-streptavidin before and after exposure to 302 nm 
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light.  DSC is typically used to monitor the heat effects upon alteration in non-covalent 
interactions in proteins.25  We also monitored the environment of the tryptophan residues by 
intrinsic fluorescence as a function of temperature.  From the data, it is apparent that the pH 
impacts the thermal stability of anti-streptavidin.  As the pH decreased, so did the apparent Tm.  
The decrease in apparent Tm values has been observed previously53 and has been attributed to the 
protonation of the amino acid side chains resulting in a reduction of β-sheet content and 
structural changes in the Fc and Fab fragments.57  A simple interpretation of the reduction in Tm is 
that it indicates a lower thermodynamic stability of the protein.53  Minimally, the Tm decreases 
because it requires less energy to unfold the antibody.  The fact that the Tm is lower at pH 3.5 
than at pH 8.0 suggests that the lower the pH, the less stable anti-streptavidin would be and the 
more aggregation we would expect.  This is in direct conflict with the observation that as the pH 
is raised, the amount of high molecular weight species increases.  Thermal unfolding by 
monitoring changes in tryptophan fluorescence was also used to study the stability of the 
photodegraded mAb.  The monitoring of the environment surrounding the remaining intact 
tryptophans by their intrinsic fluorescence showed a red shift, indicating more solvent exposed 
tryptophan residues, in the Fmax upon heating the solution which reached a plateau past the Tm.  
This method yielded overall apparent Tm values for the unexposed material that were in good 
agreement with the DSC data.  Similar to what was observed by DSC, the apparent Tm decreased 
with increasing pH, which is again in direct contrast to the trends for aggregation.  This trend 
based on pH suggests that the aggregation is not tied to the thermodynamic stability of the 
protein 
One possible explanation for this trend is based on the overall charge of the mAb at the 
lower pH.  The measured pI of the protein is 8.7 and would be expected to have a much greater 
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degree of positive charge at the lower pH resulting in charge repulsion and a concomitant 
decrease in aggregation.  It has been reported that as the amino acid side chains become 
protonated, it forces the antibody to reorganize into a new structure, the A-state.  This so called 
A-state has been reported to be relatively compact and as a result has been ascribed as the reason 
for less aggregation than expected in IgG heated samples at low pH.57 
Besides the impact of pH on the apparent melting transitions, light exposure induced 
significant changes as well.  For the three pH conditions studied, a decrease in the largest 
transition peak, as observed by DSC, which is typically assigned to the Fab domain, was 
observed after light exposure.  Differences in the other transitions aren’t as easily discernible, but 
in all cases, even after 30 minutes of exposure, the final transition, typically assigned to the CH3 
domain can be readily seen.  Broadening of the transitions upon light exposure is most readily 
seen at the higher pH’s of 5.0 and 8.0.  Similar to our observations, it has previously been 
reported that light exposure in the range of 310 nm to 700 nm of an IgG1 antibody at pH 7.2 can 
induce broadening of the unfolding peaks and has been attributed to a loss of structural 
cooperativity.25 
Interestingly, from the intrinsic fluorescence data, it is again clear that exposure to UV 
light has a profound impact on the thermal stability of anti-streptavidin.  Changes in the Fmax 
were observed at as low as 30ºC for the pH 3.5 exposed samples and at 40ºC for the pH 5.0 and 
8.0 exposed samples.  The deviations from baseline suggest thermal instability at a much lower 
temperature than for the native protein.  In simple terms, this indicates that the remaining intact 
tryptohans reside in a variety of microenvironments, some of which have become more solvent 
exposed at lower temperatures.  Again this is in contrast to the relationship between aggregation 
and pH, where the higher pH becomes more strongly aggregated.  Minimally, at lower pH values 
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there is a change in the structure of anti-streptavidin which reduces the formation of aggregates, 
in agreement with the DSC data.  From the sequence of anti-streptavidin, it can be noted that 
there are a total of 26 tryptophans, with only six being found widely dispersed throughout the 
two light chains.  The remaining 20 tryptophans can be found in the two heavy chains with a 
preponderance located in the Fab region of the antibody.  The shift in Fmax upon heating as 
observed by intrinsic fluorescence measurements would suggest that changes in the structure, 
likely the Fab, are occurring upon light exposure.  While the overall charge of anti-streptavidin is 
positive at pH 3.5, as the pH is raised anti streptavidin becomes less and less positively charged 
allowing it to become more and more susceptible to aggregation upon light exposure.  Above the 
pKa of histidine, 6.0, the imidazole side chain becomes deprotonated further reducing the overall 
positive charge and making anti streptavidin closer to neutrally charged, which might also 
explain the difference between the extent of aggregation at pH 5 and pH 8. 
In direct contrast to what we observed for anti-streptavidin, the tertiary structural analysis 
of sTNF-R1 exposed to 302 nm light showed changes in the positioning of the tryptophan and 
phenylalanine residues in asymmetric environments.39  For anti-streptavidin exposed to light, a 
close examination of the tertiary structure by near UV CD as well as 2nd derivative UV-vis 
spectroscopy and intrinsic tryptophan fluorescence at 25ºC failed to detect significant differences 
at pH 5 and 8 upon exposure under the conditions described above.  At pH 3.5, there may be a 
small difference for the 1 mg/mL sample as observed by near UV CD.  Near UV CD and 2nd 
derivative UV-vis spectra are influenced by the microenvironment of the aromatic residues and 
disulfides within the antibody, so the lack of changes observed by these techniques is suggestive 
that the tertiary structure is intact at pH 5 and 8.58   
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In agreement with the near UV CD and 2nd derivative UV-vis data, the intrinsic 
tryptophan fluorescence at 25 ºC also failed to detect a peak shift whether it was a blue shift or 
red shift, again suggesting that the tertiary structure, at least around the tryptophan residues 
remained intact.  However, the data showed in all cases a decrease in fluorescence intensity upon 
light exposure.  In this case, since excitation was accomplished at 295 nm, the predominate 
residues probed were again the 26 tryptophan residues in anti-streptavidin.  The decrease in 
fluorescence intensity upon exposure may simply be a result of the destruction of tryptophan 
residues upon exposure to 302 nm light reducing the overall quantum yield observed.59  
Interestingly, a fluorescence test for the presence of N-formylkynurenine (excitation at 315nm 
followed by emission scan at 440-450nm)39 was negative as was a fluorescence test for 
dityrosine60 (data not shown).  This is in contrast to sTNF-R1, which formed N-
formylkynurenine upon exposure to 302nm light, implicating its sole tryptophan in the 
degradation process.39  Further work will need to be conducted to elucidate the exact cause for 
the decrease in the peak intensity upon exposure. 
Far UV CD and FT-IR were used to study the impact of light exposure on the secondary 
structure of anti-streptavidin under the conditions described above.  Both methods showed the 
most dramatic differences for the pH 3.5 samples.  Upon exposure the far UV-CD pH 3.5 spectra 
showed distinct differences around the wavelength of 197 nm suggesting that there is a change in 
the extent of random coil upon exposure to light.  As pointed out earlier, the structure for all of 
the samples is dominated by an intensely negative band between 210-220nm, reflecting the β-
sheet structure of anti-streptavidin.  For all pH’s at all three concentrations there are slight 
differences observed between the exposed and the unexposed sample in the negative band at 
210-220 nm which may indicate a change in the β-sheet structure.  In good agreement with the 
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far-UV CD data, FT-IR shows the predominate structure of anti-streptavidin to be β-sheet.  The 
anti-streptavidin FT-IR spectrum is dominated by bands at approximately 1690 and 1639 cm-1  
which are often associated with β-sheet structure.  No concentration effect was observed.  There 
are also a number of additional bands from 1660 to 1680 cm-1which have been assigned to turns 
in the secondary structure.  One final band should be mentioned as well.  It is observed at 
approximately 1615 cm-1 and is considered to be associated with intermolecular β-sheet structure 
structures.  Interestingly, FTIR analysis for the 10 mg/mL anti streptavidin in 10 mM sodium 
acetate, pH 3.5 showed the most dramatic difference upon exposure for 60 minutes at 302 nm, 
primarily in the region of 1660 to 1680 cm-1 where the structure is dominated by turns.  
However, there is also some difference in the signal at 1615 cm-1.  The anti-streptavidin in 10 
mM sodium phosphate pH 8.0 showed very little difference in the secondary structure.  The pH 
5.0 sample showed only small changes in the spectrum making a definitive assessment difficult. 
Conclusions: 
From this work, it is once again very apparent that care must be exercised to protect 
monoclonal antibodies from light.  The amount of time for exposure to 302 nm to effect 
noticeable changes in anti-streptavidin was as little as 1 minute.  In contrast to sTNF-R1, anti-
streptavidin formed non-reducible covalently linked oligomers, mostly in the form of dimer and 
trimer along with higher order species.  The following pH dependence in the rate of aggregation 
was observed:  pH 3.5 < pH 5.0 < pH 8.0.  One potential explanation may be the formation of 
dithiohemiacetal and thioether cross-links.33  Further work will need to be conducted to elucidate 
the mechanism. 
Exposure of anti-streptavidin to 302 nm light resulted in changes to the apparent melting 
transitions as observed by DSC and thermal unfolding as monitored by intrinsic fluorescence.  
Here the following trend was observed:  pH 3.5 > pH 5.0 > pH 8.0.  One explanation for this 
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trend might be that as the amino acid side chains become progressively more protonated, the 
antibody is forced to reorganize into a new structure, the A-state which is relatively compact and 
reduces the potential for aggregation.57  The tertiary structure of anti-streptavidin appeared to 
remain intact, but analysis of the secondary structure revealed changes in the β-sheet structure 
with the following trend:  pH 3.5 > pH 5.0 > pH 8.0. 
Future Directions: 
 A number of different experiments would help further the current work.  A better 
understanding of the role that mAb conformation plays on the rate of aggregate formation upon 
light exposure would be beneficial.  The thermal unfolding and secondary structural changes 
upon light exposure followed the trend of pH 3.5 > pH 5.0 > pH 8.0, while the rate of 
aggregation had the opposite trend of pH 3.5 < pH 5.0 < pH 8.0.  Perhaps ANS fluorescence 
binding experiments would show the degree of surface exposure of hydrophobic groups.  H/D 
exchange with FTIR detection may help with elucidating changes in the secondary structure at 
the different pH’s upon light exposure.  There are also several experiments that would help in 
understanding the type of chemical modifications that occur during anti-streptavidin’s exposure 
to 302nm light.  The simplest would be ion exchange chromatography, either anion or cation 
which would reveal differences in the overall charge of the exposed antibody from degradation 
such as deamidation and oxidation.  Short exposure times to 302nm light of 1-5 minutes may 
show differences between the unexposed anti-streptavidin and the exposed sample.  Peptide 
mapping would help provide information on the chemical modification that lead to the formation 
of the aggregates observed.  A typical peptide mapping experiment would first involve the 
reduction of any disulfide bonds with dithiothreitol (DTT) under denaturing conditions to help 
ensure complete carboxymethylation.  Subsequent digestion of anti-streptavidin with trypsin 
would theoretically yield 53 peptide fragments of sufficient size to allow for standard analysis, 
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which is generally accomplished by reverse phase HPLC and mass spectroscopy detection.  This 
experiment would allow for the detection of chemical modifications and provide information that 
either supports or contradicts the proposed mechanism of aggregation.  Once the chemical 
modification sites are known, mutants eliminating those amino acid residues susceptible to 
degradation could be made to help confirm the mechanism and to aid in better understanding the 
role that conformation and pH play in the photodegradation process.  
 It would also be interesting to see the impact that light exposure has to the long term 
stability of anti-streptavidin.  Does the formation of aggregates by light exposure lead to an 
increased rate of aggregation or does the formation simply raise the baseline amount of 
aggregation?  Common stability indicating assays such as size exclusion HPLC, cation exchange 
HPLC, and peptide mapping would allow for the rate of aggregation and chemical modifications 
to be monitored over a series of time points. 
 The current work was conducted using the IgG1 variant of anti-streptavidin.  Although it 
has close sequence homology with the IgG2 variant, there are distinct differences between the 
two versions, particularly in the hinge region involving the disulfide structure.  The major 
difference between the subclasses arise from serine to cysteine substitutions in the hinge region 
and the flexible loop of the heavy chain of IgG2 molecules.61  This allows for a variety of 
isoforms for the IgG2 molecule which have different disulfide links.  It would be interesting to 
duplicate this work using the IgG2 variant.  Would the specific variants have different 
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